This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Bio-Techne’s 8K filing here.
Bio-Techne Company Profile
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally.
Read More
- Five stocks we like better than Bio-Techne
- Most Volatile Stocks, What Investors Need to Know
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How to Calculate Options Profits
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
